ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 84 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $13,000 | -51.9% | 7,434 | -43.2% | 0.00% | -100.0% |
Q1 2022 | $27,000 | -47.1% | 13,087 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $51,000 | -26.1% | 13,087 | -1.8% | 0.00% | -50.0% |
Q3 2021 | $69,000 | +81.6% | 13,333 | +49.9% | 0.00% | +100.0% |
Q2 2021 | $38,000 | – | 8,892 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |